Rayonier Advanced Materials is a specialty forest products company — dissolving wood pulp, cellulose specialties for filters, food, pharma, coatings. On April 21, 2026, the board announced a strategic alternatives process with Morgan Stanley and Wachtell Lipton, confirming it had "recently received unsolicited indications of interest." The CEO resigned April 16 after 3.5 months. Stock at $9.20; rejected cash bid from November was $11-12.

What the filing says

The 8-K itself is short. Two items: CEO Scott Sutton resigned effective April 16, with the Office of the CEO (CFO Marcus Moeltner + GC Jennifer Slaughter) running operations on an interim basis. Morgan Stanley is financial advisor, Wachtell Lipton is legal counsel, and the board has "received unsolicited indications of interest" — plural.

What makes the filing consequential is the sequence it completes. Prior filings and a Schedule 13D establish the timeline:

• Nov 18, 2025: American Industrial Partners (AIP) delivered an unsolicited $11-12/share cash bid when the stock was $5.52.
• Dec 18, 2025: Board rejected — "not in the best interest at this time."
• Jan 5, 2026: Board hired Sutton with PSU inducement targets at $15/$30/$45 over three years. An organic rerating structure.
• Jan 23, 2026: AIP closed a $1.5B acquisition of International Paper's Global Cellulose Fibers — the adjacent commodity-pulp platform.
• Feb 25, 2026: AIP filed Schedule 13D (active intent), 5.07% stake, $25.44M.
• Feb 27 and Mar 5, 2026: Moeltner and Slaughter made open-market purchases (transaction code P, not grants) totaling ≈$378K.
• Apr 16, 2026: Sutton resigned. No stated cause.
• Apr 21, 2026: Formal process announced with MS + Wachtell.

Segment economics: Cellulose Specialties produced $862M revenue and $160M operating income in 2025 — essentially 100% of consolidated operating profit. The rest (commodity pulp, paperboard, high-yield pulp) collectively destroyed value. Balance sheet: $779M debt, $75M cash, 3.9x leverage, -$88M free cash flow in 2025. Temiscaming DWP production was permanently ceased in Q1 2026.

What the market thinks

Stock gapped from ≈$7.50 pre-announcement to $9.20. Decomposing current price into conditional-deal ($13.90 blended) and conditional-fail ($6.40 blended) outcomes, market-implied deal probability is ≈37%. Options P/C ratio is 19.39 (extreme put skew) but total May open interest is only 3,140 contracts — retail and structured-product flow, not institutional conviction. Max pain $6 is a market-maker anchor, not a forecast. Sell-side coverage is sparse. The market still treats RYAM as a distressed levered pulp company with a wildcard strategic review.

Why the gap exists

The AIP timeline is public but unsynthesized. Each disclosure looks modest individually: a rejected bid in November, a 13D filing in February, a CEO departure in April. Read as a sequence, they describe a five-month campaign — AIP bids, board rejects, AIP escalates with a 13D cornerstone, insider buying aligns with the reality the board resisted, the hired-to-resign CEO marks the pivot, Wachtell engagement marks the endgame. The two insiders now running the company bought shares with personal money seven weeks before announcement.

Borregaard (BRG.OL) — the cleanest specialty cellulose pure-play comp — trades at 10-11x EV/EBITDA. RYAM's CS segment at that multiple implies $1.9-2.2B TEV, above current whole-company enterprise value of $1.38B. CS alone is worth more than the entire company.

Cross-checking with AIP specifically: they just paid $1.5B for GCF at ≈2.5x EBITDA. The strategic logic for adding RYAM CS at specialty multiples to that platform is explicit. AIP has an anchor position, an adjacent asset freshly closed, and a stated thesis. That's not priced.

Risks, ranked

1. Debt stack can stub equity. $779M debt means a buyer paying $12 for equity underwrites $1.58B TEV. Process failure pressures covenants and pushes equity toward $5-6. Bimodal payoff: deal at $12-15 or fail at $5-6.
2. Sutton's "no stated cause" departure. Leaves open material disagreement or pending disclosure. A separation-agreement filing could change the read.
3. Carve-out complexity caps multiples. Integrated operations make clean CS-only sales difficult. Whole-co deals trade at blends, not pure specialty.
4. Chinese capacity overhang. Borregaard flags this persistently. Buyer underwriting discounts for it.
5. AIP hasn't amended 13D up. February stake stands. If they sit out an aggressive process, the anchor weakens.

Catalysts

• ~May 5, 2026: Q1 earnings. First process-language test from interim leadership.
• May-June 2026: Typical IOI deadline window (30-60 days post-advisor engagement).
• Aug-Oct 2026: Prime deal-announcement window. MS+Wachtell process velocity median 90-180 days.
• Apr 30, 2027: Outside date for typical strategic-review resolution.

What would change our mind

• Bearish: Q1 earnings discloses covenant amendment or customer concentration loss. Sutton's separation filing reveals disagreement. AIP files 13D-A reducing stake. No 13D activity and no new filer by May 31.
• Bullish: AIP files 13D-A increasing stake or with harder language. A second strategic (Bracell/RGE, Lenzing, Sappi) files 13D. CFO or GC makes additional open-market purchases post-announcement. Analyst initiation that names AIP as anchor.

The central observation is simple: the stock trades below the level of a cash bid the board rejected five months ago, when the rejection was a bet the company could hit $15-45 organically, and the CEO hired to execute that bet has just resigned. The question is whether the next step is a higher bid or a failed process.

Evidence